Here are the hot-off-the-press revisions to CDC contraception guidelines and recommendations.

Dr Andrew Kaunitz discusses hormone receptor therapy in menopausal women and the relationship between ovarian function duration and risk for heart failure.

Dr JoAnn Manson summarizes key evidence showing that 'what's good for the heart is good for the brain.'

Dr Kathy Miller points to PARP inhibitors and pertuzumab as highpoints of the breast cancer program at the upcoming ASCO meeting, including the plenary presentation of the OlympiAD trial.

Dr Markman previews the latest research on gynecologic cancer to be presented at the upcoming ASCO meeting.

Can exogenous use of the 'love hormone' be disruptive? It's possible, says biologist and oxytocin researcher Dr Sue Carter.

Dr Arefa Cassoobhoy highlights one of the week's most important news stories for primary care.

These management strategies can help enhance the care of women with adnexal masses.

Dr JoAnn Manson presents new data about the use of vitamin D supplementation to prevent cardiovascular disease, cancer, and mortality.

For which women should a pelvic exam be considered? Dr Kaunitz gives his take on new USPSTF recommendations.